Ananiti-malaria drug touted by President Trump as a"game changer" for COVID-19 showed no benefit, according to an analysis of patients hospitalized in Veterans Health Administration medical centers.
The analysis found the two primary outcomes for people treated with hydroxychloroquine were death and the need for mechanical ventilation.
The analysis was conducted retrospectively, based on data from patients hospitalized with confirmed COVID-19 infections in all VA medical centers until April 11, 2020.
TVNL Comment: Read the second paragraph carefully. Self-anointed Dr. Trump is a charleton.
Pope Leo XIV has appointed a man who had once entered the United States as an...
The head of the US Joint Chiefs of Staff, General Dan Kane, said Russia is providing...
US President Donald Trump announced the extension of the truce between Israel and Lebanon for an...
